Chiesi USA, Inc.
Drug Recalls (Class II)
Class II
D-0402-2026
·
20260401
·
Ongoing
Product
CUROSURF (poractant alfa), 240 mg, Intratracheal Suspension, 3L Single-dose-Vial, Rx only, Chiesi USA, Inc, Cary, NC 27518, NDC 10122-510-03.
Reason for Recall
Lack of Assurance of Sterility
Distribution
Nationwide within the United States
Source: openFDA Enforcement API